190 related articles for article (PubMed ID: 2158159)
21. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
22. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
Babel N; Gabdrakhmanova L; Hammer M; Rosenberger C; Oppert M; Volk HD; Reinke P
Transpl Infect Dis; 2005; 7(3-4):133-6. PubMed ID: 16390402
[TBL] [Abstract][Full Text] [Related]
23. A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.
Haque T; Thomas JA; Parratt R; Hunt BJ; Yacoub MH; Crawford DH
Transplantation; 1997 Oct; 64(7):1028-34. PubMed ID: 9381525
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx.
Alfieri C; Tanner J; Carpentier L; Perpête C; Savoie A; Paradis K; Delage G; Joncas J
Blood; 1996 Jan; 87(2):812-7. PubMed ID: 8555507
[TBL] [Abstract][Full Text] [Related]
25. Pretransplant herpes virus serology and chronic graft-versus-host disease.
Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients.
Lazda VA
Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286
[TBL] [Abstract][Full Text] [Related]
27. [Atypical profile problem in serological diagnosis of EBV].
Varıcı Balcı FK; Özbek ÖA; Sayıner AA
Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068
[TBL] [Abstract][Full Text] [Related]
28. Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation.
Barberà JA; Martín-Campos JM; Ribalta T; Carreras E; Liopart A; Sierra J; Rozman C; Rodríguez-Roisin R
Eur Respir J; 1996 Jun; 9(6):1195-200. PubMed ID: 8804937
[TBL] [Abstract][Full Text] [Related]
29. [Variability in Epstein-Barr virus serological markers in adult kidney transplant recipients].
Lauzurica R; Frías C; Bayés B; Ausina V; Romero R
Nefrologia; 2005; 25(2):185-90. PubMed ID: 15912656
[TBL] [Abstract][Full Text] [Related]
30. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
[TBL] [Abstract][Full Text] [Related]
31. Herpes-virus immunity and acute graft-versus-host disease.
Gratama JW; Zwaan FE; Stijnen T; Weijers TF; Weiland HT; D'Amaro J; Hekker AC; The TH; de Gast GC; Vossen JM
Lancet; 1987 Feb; 1(8531):471-4. PubMed ID: 2881039
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
33. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus (EBV) associated B-cell lymphoproliferative disease following HLA identical sibling marrow transplantation for aplastic anaemia in a patient with an EBV seronegative donor.
Parry-Jones N; Haque T; Ismail M; Jones L; Hale G; Waldmann H; Gordon-Smith EC; Crawford DH; Marsh JC
Transplantation; 1999 May; 67(10):1373-5. PubMed ID: 10360594
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
[TBL] [Abstract][Full Text] [Related]
36. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
Boström L; Ringdén O; Forsgren M
Scand J Immunol; 1991 Jul; 34(1):45-52. PubMed ID: 1648786
[TBL] [Abstract][Full Text] [Related]
37. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.
Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Cox K; Krams SM
Transplantation; 1995 Feb; 59(4):519-24. PubMed ID: 7878757
[TBL] [Abstract][Full Text] [Related]
38. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
Ternák G; Szúcs G; Uj M
Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
[TBL] [Abstract][Full Text] [Related]
39. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
40. Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients.
Rosenzwajg M; Fery N; Bons V; Damaj G; Gluckman E; Gluckman J
Bone Marrow Transplant; 1999 Aug; 24(4):351-4. PubMed ID: 10467321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
